NCT02265731 2021-08-02Study Evaluating Venetoclax in Subjects With Hematological MalignanciesAbbViePhase 1/2 Completed38 enrolled
NCT01116232 2019-03-26Sirolimus, Tacrolimus, Thymoglobulin and Rituximab as Graft-versus-Host-Disease Prophylaxis in Patients Undergoing Haploidentical and HLA Partially Matched Donor Hematopoietic Cell TransplantationBarbara Ann Karmanos Cancer InstitutePhase 2 Terminated4 enrolled 4 charts